In another study, the levels of Melanoma inhibitory activity protein (MIA), S100B and tyrosinase-related protein 2 (TYRP2), known melanoma biomarkers, were evaluated in exosomes isolated from the sera of stage IV melanoma patients and healthy controls. This evidence concerns the gene DCT and melanoma.